Tetradecylamine

Endpoint summary

Description of key information

Tetradecylamine is considered as harmful if swallowed.

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

13 Jun - 07 Jul 1983

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study

Remarks:

Also in compliance with GLP.

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

GLP compliance:

yes

Test type:

standard acute method

Limit test:

no

Specific details on test material used for the study:

Name of test material (as cited in study report): Armeen C

Species:

rat

Strain:

other: BOR: WISW; SPF TNO

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Firma Winkelmann, Versuchstierzucht, 4791 Borchen 1, Gartenstraße 300, Germany
- Weight at study initiation: males: 170.1 - 190.8 g; females: 140.0 - 162.6 g
- Fasting period before study: The day before treatment, the animals were fasted for a period of 16 hours and received food 4 hours after treatment.
- Housing: in Makrolone cages (type III), max. 5 animals per cage
- Diet (e.g. ad libitum): pellets, Ssniff-R diet for rats (Ssniff Versuchstier-Diäten GmbH, 4770 Soest, Germany)
- Water (e.g. ad libitum): tap water; ad libitum; analytical controls were made periodically
- Acclimation period: approx. 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2
- Humidity (%): 45-55
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

oral: gavage

Vehicle:

other: oleum arachidis

Details on oral exposure:

VEHICLE
- Concentration in vehicle: 20% dilution of the test substance in oleum arachidis; pH 8.1

Doses:

range finding study: 1000, 2500, 5000 mg/kg
main study: 500, 1000, 1500, 2000 mg/kg

No. of animals per sex per dose:

range finding study: 2 female animals per dose
main study: 5 animals per sex per dose

Control animals:

not specified

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical signs: 20 min, 1 + 2 h, 3 + 6 h, 24 h, 48 h, 72 h and 7/14 d after treatment; weighing: at day 0 and at day 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic examination of the main organs

Statistics:

The LD50 was calculated according to a Probit Analysis, Finney´s method. (Probit Analysis, 3rd edition, Cambridge 1971)

Preliminary study:

range finding study:
1000 mg/kg: 1/2 (3 days after application)
2500 mg/kg: 2/2 (4 days after application)
5000 mg/kg: 2/2 (4 days after application)

Sex:

male/female

Dose descriptor:

LD50

Effect level:

1 300 mg/kg bw

Sex:

male

Dose descriptor:

LD50

Effect level:

1 240 mg/kg bw

Sex:

female

Dose descriptor:

LD50

Effect level:

1 388 mg/kg bw

95% CL:

1 119 - 4 440

Mortality:

500 mg/kg: male: 1/5; female: 0/5 (48 hours after administration: one male animal died)
1000 mg/kg: male: 1/5; female: 1/5 (48 hours after administration: one male animal died; 5 days after administration: one female animal died)
1500 mg/kg: male: 2/5; female: 2/5 (48 hours after administration: one male and one female animal died; 5 days after administration: a further male and female animal died)
2000 mg/kg: male: 5/5; female: 5/5 (48 hours after application: 2 male animals and one female died; 5 days after application: all males were died; 7/14 days after application: all females were died)

Clinical signs:

at all doses: reduced consciousness with apathy, abnormal position and poor posture, loss of coordination (reduced excitability), cyanosis, limited but extreme salivation, piloerection, slightly reduced breathing rate, slight hypothermia
The clinical signs were observed 20 minutes after administration and were persisted up to 7 days after aadministration. All surviving animals showed a normal habitus during the last 7 days of the observation period.

Body weight:

All surviving animals showed normal body weight gain.

Gross pathology:

Macroscopic examinations of died animals (during the study period) showed slight redness and accumulation of fluid in the gastrointestinal tract.
Macroscopic examinations of sacrificed animals (at the end of the study) revealed no abnormalities of the main organs.

Interpretation of results:

Category 4 based on GHS criteria

Conclusions:

The median lethal dose (LD50) is 1300 mg/kg bw (both genders).

Executive summary:

In an OECD TG 401 study, the test material Armeen C, a clear light-yellow, oily liquid, was orally applied to Wistar rats at doses of 500, 1000, 1500 and 2000 mg/kg bw. The substance was applied as a 20% solution in peanut oil (pH 8.1). At 500 mg/kg bw, two males died 5 and 7 days after treatment, respectively. At 1000 mg/kg bw, two males and two females died between days 5-14 (40%). At 1500 mg/kg bw, four males and four females and at 2000 mg/kg bw (80%), ten males and nine females died between days 5-14 (95%). An LD50 of 1300 mg/kg bw (1240 mg for male and 1390 mg for female rats) was calculated (probit analysis after Finney). Clinical signs, observed in all treatment groups, included apathia, slight to pronounced irregular postures, uncoordinated movements, reduced reflexes, cyanosis, salivation, piloerection, slightly reduced breathing rate and some cases of slight hypothermia. Symptoms started from 20 minutes after dosing on and were present until death or up to 7 days in survivors. After dissection of dead animals, slight reddening and liquid congregations were detected in the gastrointestinal tract. There were no pathological findings in the surviving animals.

Endpoint conclusion

Endpoint conclusion:

adverse effect observed

Dose descriptor:

LD50

Value:

1 300 mg/kg bw

Quality of whole database:

GLP and guideline compliant study.

Additional information

In an OECD TG 401 study, coco alkylmaines, as a clear light-yellow, oily liquid, were orally administered to Wistar rats at doses of 500, 1000, 1500 and 2000 mg/kg bw. The substance was applied as a 20% solution in peanut oil (pH 8.1). At 500 mg/kg bw, two males died 5 and 7 days after treatment, respectively. At 1000 mg/kg bw, two males and two females died between days 5-14 (40%). At 1500 mg/kg bw, four males and four females and at 2000 mg/kg bw (80%), ten males and nine females died between days 5-14 (95%). A LD50 of 1300 mg/kg bw (1240 mg for male and 1390 mg for female rats) was calculated.

Justification for selection of acute toxicity – oral endpoint
Only one study available

Justification for classification or non-classification

Based on the LD50 value of 1300 mg/kg bw in rats for another member of the chemical category, tetradecylamine is classified as Acute Tox. 4, H302 according to the GHS principles.